Author: Angelis Konstantinopoulos Konstantinos Giannitsas Anastasios Athanasopoulos Dionisios Spathas Petros Perimenis
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.10, Iss.2, 2009-02, pp. : 155-160
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
QOL advantage with sildenafil for erectile dysfunction
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 347, 2002-01 ,pp. :
A Risk-Benefit Assessment of Sildenafil in the Treatment of Erectile Dysfunction
By Vitezic D.
Drug Safety, Vol. 24, Iss. 4, 2001-01 ,pp. :